CFO Aurora Swithenbank provided detailed financial metrics, including a 15.6% adjusted ROE and $2.8 billion in total cash and investments at quarter-end. She also announced a $250 million increase in ...

MPS launched several new products, including a silicon carbide inverter for high-powered clean energy applications, automotive audio products utilizing DSP technology, and a battery management ...

First Bancorp (North Carolina) said its board has authorized a new share-repurchase plan for up to $40 million of the company's outstanding common stock. The plan may be modified, extended, suspended ...

Post Holdings board approved a new $500 million share repurchase authorization, which will take effect Feb. 10. The company's said Thursday its previous share repurchase plan, which had $200.2 million ...

The company also announced that its board of directors has authorized an additional $250M share repurchase plan effective through December 31, ...

Piper Sandler (PIPR) announced that its board of directors has authorized the repurchase of up to $150 million of the company’s outstanding ...

News Corporation, with a current market capitalization of $17.18 billion, disclosed ongoing transactions under its stock repurchase program, which authorizes the company to buy back up to $1 billion ...

MONTREAL - Lightspeed Commerce Inc. (TSX: LSPD) (NYSE: LSPD), a provider of point-of-sale and e-commerce software with a market capitalization of $2.19 billion, has announced the authorization of a ...

The AP Moller-Maersk stock jumped after the company announced a solid performance in the fourth quarter. The container ...

Based on the profit for 2024 and a very strong solvency ratio, the Board of Directors of Alm. Brand A/S has resolved to exercise the authority to buy back treasury shares for a total amount of up to ...

Santander has said that it intends to return €10bn to investors over the next two years through buybacks after reporting ...

GSK launched a rare £2bn share buyback and raised its growth targets on the back of strong sales of speciality medicines including cancer and HIV drugs, sending shares up as much as 6 per cent on ...